Skip to main content

Diabetes Topic Center

Featured Article

Headshots
Videos
09/13/2023
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
04/13/2023
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
News
01/26/2023
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been...
01/26/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
01/17/2023
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
01/13/2023
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3...
01/13/2023
First Report Managed Care
News
06/08/2022
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked...
06/08/2022
First Report Managed Care
News
03/04/2022
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan...
03/04/2022
First Report Managed Care
News
01/17/2022
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care
News
12/22/2021
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that...
12/22/2021
First Report Managed Care
News
12/20/2021
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
11/24/2021
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care

Newsfeed

News
01/26/2023
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been...
01/26/2023
First Report Managed Care
News
01/13/2023
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3...
01/13/2023
First Report Managed Care
News
06/08/2022
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked...
06/08/2022
First Report Managed Care
News
03/04/2022
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan...
03/04/2022
First Report Managed Care
News
01/17/2022
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care
News
12/22/2021
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that...
12/22/2021
First Report Managed Care
News
12/20/2021
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
11/24/2021
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care
News
11/15/2021
“These findings support that people with diabetes, hypertension, [and] obesity should be prioritized for vaccination in order to limit the higher death rates in hospital,” researchers wrote.
“These findings support that people with diabetes, hypertension, [and] obesity should be prioritized for vaccination in order to limit the higher death rates in hospital,” researchers wrote.
“These findings support that...
11/15/2021
First Report Managed Care
News
11/09/2021
“The disproportionate burden of obesity and type 2 diabetes on racial and ethnic minority communities signals an urgent need to accelerate the implementation and coordination of the MDPP,” researchers wrote. 
“The disproportionate burden of obesity and type 2 diabetes on racial and ethnic minority communities signals an urgent need to accelerate the implementation and coordination of the MDPP,” researchers wrote. 
“The disproportionate burden of...
11/09/2021
First Report Managed Care
News
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
News
11/11/2024
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and...
11/11/2024
First Report Managed Care
News
11/08/2024
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based...
11/08/2024
First Report Managed Care
News
11/08/2024
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy...
11/08/2024
First Report Managed Care
News
11/07/2024
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag...
11/07/2024
First Report Managed Care
News
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
11/05/2024
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies...
11/05/2024
First Report Managed Care
News
11/01/2024
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
10/30/2024
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care
News
10/29/2024
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of...
10/29/2024
First Report Managed Care

Insights

Headshots
Videos
09/13/2023
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
04/13/2023
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
01/17/2023
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network
Headshot of German Hernandez, fellow of the American Society of Nephrology
Commentary
11/18/2021
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides...
11/18/2021
First Report Managed Care
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
Interview
03/17/2020
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD,...
03/17/2020
First Report Managed Care
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
Interview
03/10/2020
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive...
03/10/2020
First Report Managed Care
Interview
07/09/2019
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president...
07/09/2019
First Report Managed Care
Interview
04/17/2019
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior...
04/17/2019
First Report Managed Care

Interactive Features